All In Biotech

Free tool

FAERS Monitor: Zilxi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213690 or its brand name (Zilxi, Minocycline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

11,615

Serious

8,929

77% of reports

Hospitalization

3,776

Death reported

1,645

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,974
  • off label use1,482
  • nausea1,075
  • pain1,019
  • arthralgia1,001
  • fatigue957
  • drug intolerance913
  • rash909
  • drug hypersensitivity908
  • rheumatoid arthritis879
  • joint swelling873
  • headache802
  • condition aggravated753
  • diarrhoea751
  • pneumonia749

Reports by year received

View as table
YearReports
200411
200552
20067
20072
20086
200979
201086
201199
2012233
2013416
2014431
2015539
2016806
2017871
2018894
20191,143
20201,001
2021762
2022695
2023877
20241,202
2025966
2026437

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,544 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug intoleranceSignal91317.316.213,908
rheumatoid arthritisSignal87914.113.210,679
joint swellingSignal87313.212.49,803
drug hypersensitivitySignal9088.58.06,057
condition aggravatedSignal7534.54.22,067
arthralgiaSignal1,0014.44.12,642
pneumoniaSignal7494.23.91,845
rashSignal9093.83.61,893
off label useSignal1,4823.12.92,150
painSignal1,0193.02.81,402
drug ineffectiveSignal1,9742.72.62,276
nauseaSignal1,0752.52.3967
headacheSignal8022.32.2617
fatigueSignal9572.22.1670
diarrhoeaSignal7512.12.0450

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.